Binningen, Switzerland

Johannes Aebi

USPTO Granted Patents = 63 

 

 

Average Co-Inventor Count = 7.2

ph-index = 6

Forward Citations = 148(Granted Patents)

Forward Citations (Not Self Cited) = 124(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Basle, CH (2004 - 2008)
  • Binningen, CH (2009 - 2018)
  • Basel, CH (1996 - 2020)

Company Filing History:


Years Active: 1996-2020

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Targeted Notch Pathway Inhibitors
Spirodiamine Derivatives
Aldosterone Synthase Inhibitors
Dihydroquinoline Compounds
Phenyl-Dihydropyridine Derivatives
Bicyclic Compounds
Heterocyclic Compounds
Imidazole Derivatives
Aminoalkylamide Derivatives
Indole Derivatives
Thiazolyl-Indole Derivatives
2,3-Oxidosqualene-Lanosterol Cyclase Inhibitors
63 patents (USPTO):Explore Patents

Title: Johannes Aebi - Innovative Inventor from Binningen, CH

Introduction: Johannes Aebi is a renowned inventor hailing from Binningen, Switzerland, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Johannes Aebi holds several patents in the areas of renewable energy, sustainable agriculture, and advanced materials, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Johannes Aebi has worked with leading research institutions and universities to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Johannes Aebi has collaborated with top companies, innovative startups, and visionary entrepreneurs to bring his inventions to the market, fostering a culture of innovation and progress.

Conclusion: Johannes Aebi's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor, shaping the landscape of technology and science for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…